ResMed Inc/ US7611521078 /
2024-04-18 9:21:52 PM | Chg. +3.05 | Volume | Bid9:21:54 PM | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
176.91USD | +1.75% | 62,295 Turnover: 11.08 mill. |
176.00Bid Size: 5,000 | -Ask Size: - | 26.02 bill.USD | 1.00% | 28.90 |
GlobeNewswire
04-10
CHILDREN’S WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH
GlobeNewswire
03-06
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Per...
GlobeNewswire
03-05
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
GlobeNewswire
02-15
ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communi...
GlobeNewswire
02-12
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions abo...
GlobeNewswire
02-06
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth...
GlobeNewswire
01-29
MatrixCare Forges Strategic Partnership with Tranzion, a Subsidiary of NHC, to Expand EHR Services f...
GlobeNewswire
2023-12-29
Visionary Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its ...
GlobeNewswire
2023-12-27
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
2023-12-20
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Pote...
GlobeNewswire
2023-12-11
ResMed Secures Significant Victory in Patent Fight Against New York University
GlobeNewswire
2023-12-07
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally